Topical co-delivery of platelet rich fibrin and tranexamic acid does not decrease blood loss in primary total knee arthroplasty compared to the standard of care: a prospective, randomized, controlled trial

被引:6
|
作者
Tandogan, Reha N. [1 ]
Polat, Metin [1 ]
Beyzadeoglu, Tahsin [2 ,3 ]
Karabulut, Erdem [4 ]
Yildirim, Kerem [3 ,5 ]
Kayaalp, Asim [1 ]
机构
[1] Ortoklin & Cankaya Orthoped, Cinnah Caddesi 51-4, TR-06680 Ankara, Turkey
[2] Halic Univ, Orthopaed & Traumatol, Bagdat Cad 333 Erenkoy, TR-34738 Istanbul, Turkey
[3] Beyzadeoglu Clin, Bagdat Cad 333 Erenkoy, TR-34738 Istanbul, Turkey
[4] Hacettepe Univ, Dept Biostat, Sihhiye Campus, Ankara, Turkey
[5] Istanbul Gelisim Univ, Orthopaed & Traumatol, Bagdat Cad 333 Erenkoy, TR-34738 Istanbul, Turkey
关键词
Platelet rich fibrin; Tranexamic acid; Total knee arthroplasty; Blood loss; TOURNIQUET USE; MANAGEMENT STRATEGIES; CLINICAL-TRIAL; METAANALYSIS; TRANSFUSION; SUPERIOR; EFFICACY; SEALANT; HIP;
D O I
10.1007/s00167-020-05938-1
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Purpose The purpose of this study was to evaluate the efficacy of intra-operative co-administration of tranexamic acid (TA) and platelet rich fibrin (PRF) using a proprietary co-delivery system on the amount of blood loss, early functional outcomes and wound complications after primary total knee arthroplasty (TKA). The intervention was compared to the standard of care (combined intravenous & topical TA) in a prospective, randomized, blinded setting. Methods 80 patients undergoing primary cemented TKA without tourniquet were prospectively randomized into control (combined intravenous and topical TA) and PRF (intra-venous TA and co-delivery of topical PRF and TA) groups after informed consent. Total blood loss, drainage blood loss, knee range of motion, VAS pain scores, length of stay and wound complications were analysed. Data collection was performed in a double blind manner on days 1, 3 and 21. Results There was no statistically significant difference in drainage blood loss (550 ml vs. 525 ml,p = 0.643), calculated total blood loss on day 1 (401 ml vs. 407 ml,p = 0.722), day 3 (467 ml vs 471 ml,p = 0.471) and day 21 (265 ml vs. 219 ml,p = 0.082) between the PRF and control groups respectively. The PRF group had a small but statistically significant increase in median knee extension in the early post-operative period, however this difference evened out at 3 weeks. No significant difference could be demonstrated between the PRF and control groups in length of stay, VAS pain scores, narcotic usage, wound complications and knee flexion at all time points. Conclusions The topical co-delivery of PRF and TA does not significantly decrease blood loss in primary TKA compared to the standard of care. Slightly better active knee extension in the first 3 postoperative days can be achieved, however this benefit is not clinically relevant.
引用
收藏
页码:519 / 528
页数:10
相关论文
共 50 条
  • [31] Influence of tranexamic acid on postoperative autologous blood retransfusion in primary total hip and knee arthroplasty: a randomized controlled trial
    Oremus, Kresimir
    Sostaric, Sinisa
    Trkulja, Vladimir
    Haspl, Miroslav
    TRANSFUSION, 2014, 54 (01) : 31 - 41
  • [32] Efficacy of oral tranexamic acid on blood loss in primary total hip arthroplasty using a direct anterior approach: a prospective randomized controlled trial
    Zhao, HaiYan
    Xiang, MaoYing
    Xia, YaYi
    Shi, Xiaojun
    Pei, Fu-Xing
    Kang, PengDe
    INTERNATIONAL ORTHOPAEDICS, 2018, 42 (11) : 2535 - 2542
  • [33] Tranexamic Acid to Reduce Blood Loss After Bilateral Total Knee Arthroplasty A Prospective, Randomized Double Blind Study
    MacGillivray, Robin G.
    Tarabichi, Samih B.
    Hawari, Marwan F.
    Raoof, Nayzak T.
    JOURNAL OF ARTHROPLASTY, 2011, 26 (01) : 24 - 28
  • [34] Platelet-Rich Plasma Does Not Decrease Blood Loss in Total Knee Arthroplasty
    Tingstad, Edwin M.
    Bratt, Sarah N.
    Hildenbrand, Kasee J.
    O'Malley, Brittany A.
    Mitchell, Elisabeth R.
    Gaddis, Corinne E.
    Jacobson, Charles A.
    ORTHOPEDICS, 2015, 38 (05) : E434 - E436
  • [35] Temporary clamping of drain combined with tranexamic acid reduce blood loss after total knee arthroplasty: a prospective randomized controlled trial
    Keerati Chareancholvanich
    Pichet Siriwattanasakul
    Rapeepat Narkbunnam
    Chaturong Pornrattanamaneewong
    BMC Musculoskeletal Disorders, 13
  • [36] Comparison of 3 Routes of Administration of Tranexamic Acid on Primary Unilateral Total Knee Arthroplasty: A Prospective, Randomized, Controlled Study
    Yuan, Xiangwei
    Li, Bin
    Wang, Qiaojie
    Zhang, Xianlong
    JOURNAL OF ARTHROPLASTY, 2017, 32 (09) : 2738 - 2743
  • [37] Intra-Articular Tranexamic Acid Mitigates Blood Loss and Morphine Use After Total Knee Arthroplasty. A Randomized Controlled Trial
    Laoruengthana, Artit
    Rattanaprichavej, Piti
    Rasamimongkol, Supachok
    Galassi, Monton
    Weerakul, Santi
    Pongpirul, Krit
    JOURNAL OF ARTHROPLASTY, 2019, 34 (05) : 877 - 881
  • [38] Topical vs Intravenous Tranexamic Acid in Reducing Blood Loss After Bilateral Total Knee Arthroplasty: A Prospective Study
    Aggarwal, Aditya K.
    Singh, Nagmani
    Sudesh, Pebam
    JOURNAL OF ARTHROPLASTY, 2016, 31 (07) : 1442 - 1448
  • [39] Efficacy and Systemic Absorption of Peri-articular Versus Intra-articular Administration of Tranexamic Acid in Total Knee Arthroplasty: A Prospective Randomized Controlled Trial
    Pinsornsak, Piya
    Phunphakchit, Jakkarin
    Boontanapibul, Krit
    ARTHROPLASTY TODAY, 2021, 11 : 1 - 5
  • [40] The comparative efficacy and safety of topical and intravenous tranexamic acid for reducing perioperative blood loss in Total knee arthroplasty- A randomized controlled non-inferiority trial
    George, Jefferson
    Eachempati, Krishna Kiran
    Subramanyam, Koushik Narayan
    Reddy, A. V. Gurava
    KNEE, 2018, 25 (01) : 185 - 191